Paper Details

  1. Home
  2. Paper Details

Treatment of hepatitis C: a systematic review.

Author: KohliAnita, KottililShyam, ShafferAshton, ShermanAmy

ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, N.I.H., ExtramuralResearch funding provided by the NIH to external research institutions and researchers.
Research Support, N.I.H., IntramuralFunding provided by the NIH for research projects within the NIH.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Over 185 million people worldwide have hepatitis C, and about 20% of them develop serious liver damage. New medications called direct-acting antivirals are being developed to eliminate the hepatitis C virus without the need for interferon, which is a standard but sometimes challenging treatment.
Paper Details　
Original Abstract of the Article :
Hepatitis C virus (HCV) infects more than 185 million individuals worldwide. Twenty percent of patients chronically infected with HCV progress to cirrhosis. New, simpler therapeutics using direct-acting antivirals that target various stages of the HCV life cycle are in development to eradicate HCV w...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1001/jama.2014.7085

データ提供：米国国立医学図書館（NLM）

Hepatitis C Treatment: A New Era in the Desert of Viral Infections

The battle against viral infections, like a relentless desert wind, continues to demand innovative strategies. Hepatitis C virus (HCV), a persistent threat, infects millions worldwide, with a significant proportion developing cirrhosis. This study, like a research expedition into the heart of this desert, explores the latest advancements in HCV treatment.

Researchers, like intrepid explorers, highlight the development of new, simpler therapeutics, like a refreshing oasis in the desert, using direct-acting antivirals that target specific stages of the HCV life cycle. These therapies, like a map guiding travelers through a treacherous landscape, offer the potential to eradicate HCV without the need for interferon.

This study, like a compass pointing towards a brighter future, underscores the rapid progress in the fight against HCV, offering hope for a world free from this debilitating infection.

A New Dawn in the Hepatitis C Desert

The development of these new, simpler therapies, like a blooming flower in the desert, marks a significant breakthrough in HCV treatment. This offers a glimmer of hope for a future where HCV can be effectively managed and eradicated, relieving the burden on millions worldwide.

Navigating the Hepatitis C Desert: A Call for Vigilance

While the development of these new therapies is promising, it's crucial to remain vigilant in our fight against HCV. The desert of viral infections can be unpredictable, and it's essential to continue research and develop strategies to prevent, treat, and ultimately eliminate this global health threat.

Dr.Camel's Conclusion

This study, like a caravan crossing a vast desert, brings us closer to understanding the complex terrain of hepatitis C. The researchers, like seasoned explorers, have uncovered valuable insights into the potential of direct-acting antivirals, offering a beacon of hope for a world free from this debilitating infection. As we continue our journey through the desert of viral infections, this study serves as a reminder of the importance of innovation, perseverance, and collaboration in our quest to find effective solutions for the health challenges facing our world.

Date :
  1. Date Completed 2014-09-10
  2. Date Revised 2022-04-10
Further Info :

Pubmed ID

25117132

DOI: Digital Object Identifier

10.1001/jama.2014.7085

Related Literature

Article Analysis
・Effective treatment of hepatitis c
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.